Compare Logitech International SA (LOGI) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Stryker Corporation — how do they compare? Logitech International SA trades at $101.7 (market cap $14.65B), while Stryker Corporation trades at $314.62 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 8.4× Logitech International SA's market cap, and Logitech International SA pays the higher dividend (1.67%). Which is the better fit depends on your goals.
| LOGI | SYK | |
|---|---|---|
Market Cap | $14.65B | $122.35B |
Sector | Technology | Technology |
52-Week High | $126.69 | $403.53 |
52-Week Low | $85.84 | $282.58 |
Enterprise Value | $13.00B | $134.10B |
Dividend Yield | 1.67% | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
